25 May 2013
Keywords: sr, pharma, initiates, ph, rtp-801i, study, london
Article | 12 February 2007
London, UK-based SR Pharma says that US collaboration partner Quark Biotech has started a Phase I clinical trial with RTP-801 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 February 2007
24 May 2013
© 2013 thepharmaletter.com